KMTS Kestra Medical Technologies, Ltd. - Common Stock

NAS · US · Healthcare · Medical Instruments & Supplies · kestramedical.com

27.50USD+0.26%Mkt Cap: 1.63B $P/E: —Today

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic inte…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap1.63B USD

Enterprise Value1.51B USD

Revenue (TTM)106.73M USD

Gross Profit48.86M USD

Net Income (TTM)-131.61M USD

Revenue/Share1.91 USD

Last Price27.50 USD

Fiscal Year EndApr 2026

MR QuarterJul 2026

Employees443

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-13.35

PEG—

EV/EBITDA-11.26

EV/Revenue14.16

P/S15.31

P/B7.31

EPS (TTM)-2.67

EPS (Forward)-2.06

52W Range

17.3480% of range30.00

52W High30.00 USD

52W Low17.34 USD

Profitability

Gross Margin51.37%

Oper. Margin-121.59%

EBITDA Margin-125.72%

Profit Margin-138.36%

ROE-50.69%

ROA-36.72%

Growth

Revenue Growth59.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-81.70M USD

CapEx (TTM)35.42M USD

FCF Margin-67.49%

FCF Yield-4.41%

Net Debt-122.47M USD

Net Debt/EBITDA0.91

Balance Sheet

Debt/Equity0.18

Current Ratio4.69

Quick Ratio4.44

Book Value/Sh3.75 USD

Cash/Share3.34 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)30.29 USD

Upside (mean)+10.1%

Target Range28.00 USD – 32.00 USD

28.00+10.1% to mean32.00

# Analysts7

Ownership

Shares Out.59.56M

Float33.70M

Insiders5.26%

Institutions101.75%

Short Interest

Short Ratio10.1d

Short % Float11.13%

Short % Out.5.24%

Shares Short3.12M

Short (prev mo.)3.02M

Technical

SMA 5025.74 (+6.8%)

SMA 20023.60 (+16.5%)

Beta—

S&P 52W Chg14.58%

Avg Vol (30d)369.94K

Avg Vol (10d)328.51K

Technical Indicators

RSI (14)57.9

MACD0.6220

MACD Signal0.3135

MACD Hist.+0.3085

BB Upper28.95 USD

BB Middle25.62 USD

BB Lower22.30 USD

BB Width25.98%

ATR (14)1.365 USD

Vol Ratio (20d)0.58x